EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection

Although substantial progress has been made in managing COVID-19, it is still difficult to predict a patient’s prognosis. We explored the epigenetic signatures of COVID-19 in peripheral blood using data from an ongoing prospective observational study of COVID-19 called the Norwegian Corona Cohort St...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yunsung, Riskedal, Espen, Kalleberg, Karl Trygve, Istre, Mette, Lind, Andreas, Lund-Johansen, Fridtjof, Reiakvam, Olaug, Søraas, Arne V. L., Harris, Jennifer R., Dahl, John Arne, Hadley, Cathrine L., Jugessur, Astanand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261254/
https://www.ncbi.nlm.nih.gov/pubmed/35798818
http://dx.doi.org/10.1038/s41598-022-15467-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261254/
https://www.ncbi.nlm.nih.gov/pubmed/35798818
http://dx.doi.org/10.1038/s41598-022-15467-1

Ejemplares similares